Tirzepatide is the first FDA-approved medication for obesity that activates both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor
Type 1 and Type 2 diabetes have distinct pathophysiology and different coding hierarchies within ICD-10-CM
Galectin1 deletion in mice causes bone loss via impaired osteogenic differentiation potential of BMSCs
ORCID: Affiliation: 3 Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, USA These authors contributed equally to this work
[38] The presence of narrow-angle glaucoma represents a relative contraindication, as the anticholinergic properties of mirtazapine could potentially precipitate acute angle-closure episodes in susceptible patients
This change also reflects potential considerations regarding tolerability, clinical outcomes, and affordability